T2 Biosystems Inc (NASDAQ:TTOO) has a beta value of 0.34 and has seen 3.45 million shares traded in the last trading session. The company, currently valued at $12.85M, closed the last trade at $0.51 per share which meant it gained $0.08 on the day or 19.77% during that session. The TTOO stock price is -1543.14% off its 52-week high price of $8.38 and 17.65% above the 52-week low of $0.42. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.06 million shares traded. The 3-month trading volume is 504.32K shares.
T2 Biosystems Inc (NASDAQ:TTOO) trade information
Sporting 19.77% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the TTOO stock price touched $0.51 or saw a rise of 7.09%. Year-to-date, T2 Biosystems Inc shares have moved -91.87%, while the 5-day performance has seen it change 2.62%. Over the past 30 days, the shares of T2 Biosystems Inc (NASDAQ:TTOO) have changed -59.52%. Short interest in the company has seen 0.83 million shares shorted with days to cover at 1.26.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wall Street analysts have a consensus price target for the stock at $5, which means that the shares’ value could jump 89.8% from current levels. The projected low price target is $5.0 while the price target rests at a high of $5.0. In that case, then, we find that the current price level is -880.39% off the targeted high while a plunge would see the stock gain -880.39% from current levels.
T2 Biosystems Inc (TTOO) estimates and forecasts
The company’s shares have lost -89.70% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 68.62% over the past 5 years.
TTOO Dividends
T2 Biosystems Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
T2 Biosystems Inc (NASDAQ:TTOO)’s Major holders
Insiders own 10.17% of the company shares, while shares held by institutions stand at 73.51% with a share float percentage of 81.83%. Investors are also buoyed by the number of investors in a company, with T2 Biosystems Inc having a total of 24.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund . As of Jun 30, 2024 , the former fund manager holds about 1.48% shares in the company for having 311.44 shares of worth $0.16 million while later fund manager owns 37.74 shares of worth $19246.0 as of Sep 30, 2024 , which makes it owner of about 0.18% of company’s outstanding stock.
